Last Updated: May 26, 2023, 05:15 IST
Washington DC, United States of America (USA)
Neuralink logo and Elon Musk photo are seen in this illustration taken on December 19, 2022. (Reuters/Dado Ruvic/Illustration)
Neuralink said clearance from the US Food and Drug Administration for its first in-human clinical study is “an important first step” for its technology.
Elon Musk’s start-up Neuralink on Thursday said it has gotten approval from US regulators to test its brain implants in people.
Neuralink said clearance from the US Food and Drug Administration for its first in-human clinical study is “an important first step” for its technology, which is intended to let brains interface directly with computers.
(This story has not been edited by News18 staff and is published from a syndicated news agency feed – AFP)
Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.
GIPHY App Key not set. Please check settings